Circulating mitochondria in deceased organ donors are associated with immune activation and early allograft

Justin Pollara1, R Whitney Edwards1, Liwen Lin1

  • 1Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.

JCI Insight
|August 10, 2018
PubMed

Insights

Systemic inflammation in deceased organ donors involves mitochondria-derived damage-associated molecular patterns (mtDAMPs). Elevated mtDAMPs correlate with organ transplant dysfunction, suggesting pre-procurement donor inflammation targeting improves outcomes.

Area of Science:

  • Immunology
  • Transplantation Biology
  • Cellular Biology

Background:

  • Deceased organ donation for transplantation is linked to unexplained systemic inflammation.
  • Mitochondria-derived damage-associated molecular patterns (mtDAMPs) are implicated in systemic inflammation following trauma.

Purpose of the Study:

  • To investigate the role of mtDAMPs in systemic inflammation in deceased organ donors.
  • To explore the correlation between donor mtDAMPs and early allograft dysfunction.

Main Methods:

  • Analysis of inflammatory cytokines, chemokines, and mtDAMPs in donor blood.
  • Neutrophil activation assays and identification of neutrophil-activating factors.
  • Electron microscopy and flow cytometry to detect circulating mitochondria.
  • Correlation analysis between donor mtDAMPs and liver transplant outcomes.

Main Results:

  • Elevated inflammatory cytokines and chemokines in donor blood correlated with mtDAMP levels.
  • Donor neutrophils were activated, with plasma containing a neutrophil-activating factor.
  • Free and membrane-bound mitochondria were elevated in donor plasma.
  • Donor plasma mitochondrial DNA levels correlated with early allograft dysfunction in liver transplant recipients.

Conclusions:

  • Circulating mtDAMPs contribute to systemic inflammation in deceased organ donors.
  • mtDAMPs may play a role in early allograft dysfunction after liver transplantation.
  • Targeting donor inflammation prior to organ procurement is a potential strategy to improve transplant outcomes.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...